The sympathetic nervous system plays a role during chronic inflammation. Since levels of nerve growth factor (NGF) are high in inflamed tissues and, in sensory neurons, NGF controls nociception by regulating neuronal sensitivity to noxious stimuli, we hypothesize that NGF also sensitizes sympathetic neurons to bradykinin (BK), a proinflammatory peptide. We cultured rat superior cervical ganglion (SCG) neurons in the presence or absence of NGF. To assess the response of SCG neurons to Bk, we measured cytoplasmic Ca 2þ elevations induced by an acute application of Bk. We found Ca 2þ elevation to be increased 3-fold in the presence of NGF. These Ca 2þ elevations in the presence of NGF depended on external Ca 2þ and depolarization of the plasma membrane. Next, we assessed the effect of Bk on the membrane potential by electrophysiological recordings. NGF-treated neurons were significantly depolarized after Bk application, while neurons cultured in the absence of NGF showed no change in membrane potential with Bk. How does NGF render SCG neurons more responsive to a Bk stimulus? We first tested whether NGF application alters BK-induced M current inhibition. Interestingly, we observed full inhibition of M current upon application of BK with and without culture in NGF. Next, we asked whether incubation of SCG neurons with NGF alters activity of other ion channels. One of the ion channels tested, KCa1.1 (Maxi K þ channel), was reduced in current density by 50% in neurons cultured in the presence of NGF. In addition, inhibition of KCa1.1 channels with iberiotoxin in SCG neurons cultured in the absence of NGF depolarized the plasma membrane potential after Bk application. In conclusion, NGF increased Bk-induced electrical excitability of rat SCG neurons by reducing a repolarizing current mediated by KCa1.1 channels. Supported by NIH grant NS008174.
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Postnatal Development of K V Currents in Cultured Small Mouse Dorsal Root Ganglion (DRG) Neurons Glenn Regnier, Elke Bocksteins, Gerda Van de Vijver, Dirk J. Snyders, Pierre-Paul van Bogaert. University of Antwerp, Antwerp, Belgium. Voltage-gated potassium (Kv) channels play an important role in the regulation of the electrophysiological properties of neurons. Neuronal excitability depends on the spatial and temporal expression of many different Kv subunits. Small dorsal root ganglion (DRG) neurons exhibit four different voltagegated K þ currents: the M current (I M ), the hyperpolarization-activated current (I H ), the transient outward current (I A ), and the delayed rectifier current (I K ). It has been demonstrated that~60% of I K is carried by both homotetrameric Kv2.1 channels and heterotetrameric channels consisting of Kv2.1 and silent Kv subunits (i.e. Kv5-Kv6 and Kv8-Kv9) while Kv1.4, Kv3.4 and members of the Kv4 subfamily underlie I A . Little is known about the postnatal development of I K and I A and how these developmental changes influence the electrophysiological properties of small DRG neurons. Here we report a decrease of the stromatoxin (ScTx)-sensitive component of the whole-cell outward DRG current during postnatal development: the fraction of ScTx-sensitive current decreased from 64% to 51% between 1 month and 3 months old mice. ScTx is a gating modifier of both Kv4.2-and Kv2-containing channels and therefore this decrease could reflect a decrease in expression of one or more of these Kv subunits during development. However, the fraction of the anti-Kv2.1 antibody-sensitive current -which only reflects Kv2-containing channelsincreased between 2 weeks and 2 months old mice from 32% to 42% of the whole-cell DRG current. These results together suggest that the decrease in the ScTx-sensitive component is due to a decrease in Kv4.2 expression. Furthermore, these results suggest that the balance between I A and I K and consequently the electrophysiological properties change during the postnatal development of small DRG neurons. Mammalian spermatozoa gain their competence to fertilize an oocyte as they travel through the female genital tract. This process -termed capacitationgoes along with an elevation of sperm intracellular calcium and a membrane hyperpolarization. The latter is evoked by K þ efflux. However, the molecular identity of the potassium channel of human spermatozoa (hKSper) is unknown. Here, we characterize hKSper and show that this chanel is regulated by intracellular calcium but is insensitive to intracellular alkalinization. We also demonstrate that human KSper is inhibited by charybdotoxin, iberiotoxin and paxilline, while mouse KSper is insensitive to these compounds. These properties suggest that the Slo1 ion channel is the molecular identity for hKSper. We show that Slo1 is localized to the sperm flagellum and is inhibited by progesterone. Inhibition of hKSper by progesterone, in turn, may depolarize the spermatozoon to open the calcium channel CatSper, thus raising [Ca 2þ ] to produce hyperactivation and allowing sperm to fertilize an oocyte.
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Modulation of Sarcolemmal ATP-Sensitive Potassium Channels by Atrial Natriuretic Peptide in Ventricular Cardiomyocytes Dai-Min Zhang, Yu-Fung Lin. Physiology and Membrane Biology, University of California, Davis, Davis, CA, USA. ATP-sensitive potassium (K ATP ) channels couple cell metabolic status to membrane excitability and are crucial for stress adaptation in the heart. Natriuretic peptides (NPs) produced by the heart, the vasculature and the kidney exert physiologically important actions such as natriuresis and inhibition of sympathetic tone and cardiomyocyte hypertrophy. Our recent study reveals that the gaseous messenger nitric oxide evokes cardiac K ATP channel stimulation via activation of soluble guanylyl cyclase and subsequently a cGMPdependent signaling pathway. Binding of NPs like atrial natriuretic peptide (ANP) to the type 1 NP receptor (NPR-A) also increases intracellular cGMP level, through activating guanylyl cyclase intrinsic to the receptor; however, how ANP modulates the function of cardiac K ATP channels remains to be established. By performing cell-attached patch recordings in ventricular cardiomyocytes acutely isolated from adult rabbits, we found that the singlechannel activity of sarcolemmal K ATP (sarcK ATP ) channels induced by sodium azide through metabolic inhibition was potentiated by addition of ANP (100 nM) (n=16), whereas the potentiation by ANP was abolished when the NPR-A antagonist anantin (1 mM) was coapplied (n=5); these findings suggest that the stimulatory action of ANP is mediated by NPR-A activation, which may depend on generation of diffusible cGMP. Indeed, sarcK ATP channel stimulation by ANP in intact ventricular myocytes was significantly abated by inhibition of cGMP-dependent protein kinase (PKG) with KT5823 (1 mM) (n=5). Moreover, the ANP effect was prevented by selective suppression of extracellular signal-regulated protein kinase (ERK)1/2 (n=6) and Ca 2þ / calmodulin-dependent protein kinase II (CaMKII) (n=6). Collectively, here we demonstrate that the polypeptide hormone ANP positively modulates ventricular K ATP channel function via activation of NPR-A, PKG, ERK1/2 and CaMKII. By opening myocardial K ATP channels, this signaling pathway may regulate cardiac excitability and contribute to cytoprotection against ischemia-reperfusion injury. ATP-sensitive potassium (KATP) channels are complexes of inwardlyrectifying Kir channels (Kir6.x) and sulfonylurea receptors (SUR). These two subunits work together to encode sensitivity to intracellular adenine nucleotides (ATP and ADP) and other regulatory ligands including PIP2. We investigated the kinetics of ATP-dependent regulation of KATP (Kir6.2 þ SUR1) channels using rapid concentration jumps. WT Kir6.2 channels rapidly reopen after washout of ATP, with a time constant of~60 ms. Extending similar kinetic measurements to mutants around the bundle crossing revealed modest effects on gating kinetics despite significant changes in ATP sensitivity. However, we identified a pair of highly conserved neighboring amino acids (Trp68, Lys170) that controls the rate of channel recovery and inhibition by ATP. Mutations of Trp68 or Lys170 have the paradoxical effect of dramatically slowing the kinetics of channel opening, while increasing channel open probability. Formalization of the transition state effects of these residues using phi-value analysis revealed a consistent steep negative slope. This finding implies that Tuesday, February 18, 2014 541a these residues play a specific role in lowering the transition state energy barrier between open and closed channel states. The demonstration of a negative phi-value is unique for an ion channel gating process, and diverges from interpretations that use phi-values to place specific residues in the spatial and temporal progression through the transition energy landscape. Using nonsense suppression for unnatural amino acid incorporation, we demonstrate the requirement for a planar amino acid at Kir6.2 position 68, potentially required to localize the ε-amine of Lys170 in the PIP2 binding site. Our findings identify a discrete pair of residues with an essential role for controlling gating kinetics of Kir channels. Inspection of the architecture of Kir channels reveals a non-covalent interface between the 'ligand-sensing' C-terminal domain (CTD) and the canonical poreforming 'gating domain' formed by the TM1 and TM2 transmembrane helices. This interface is involved in transduction of ligand binding, and intact coupling between the CTD and TMD of Kir6.2 channels has been proposed to be crucial for propagation of gating effects induced by intracellular ligands. However, many mutations in this interfacial region prevent channel function and thereby preclude functional studies to interrogate the domain interface. We have developed a novel rescue mechanism that circumvents this problem, and we have applied this method to scan the functional contributions of residues in the CTD-TMD interface of Kir6.2 channels. Overall, residues cluster into three distinct functional types, based on their impact on ATP sensitivity and gating kinetics of the F168E background mutation used for functional rescue. Most loss-of-function mutations are classified as 'efficiently coupled', and their ATP sensitivity is only modestly affected by introduction of mutations. A second group of mutations comprises residues in the ATP binding site, which are 'efficiently coupled' but are profoundly insensitive to ATP. Most interestingly, our studies reveal a subset of 'uncoupling' mutations that form a network between the C-linker, G-loop, C-D loop, and slide helix of the channel. These residues exhibit an unusual combination of low open probability (or complete loss of function) combined with profound ATP insensitivity. The identification of mutations that uncouple the TMD and CTD distinguishes unique gating roles for residues that are required for channel function, and highlights the importance of a rescue approach to understand the impact of loss of function mutations.
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Mechanism of Carbamazepine Mediated Rescue of Trafficking Defective Mutant KATP Channels Prasanna Devaraneni, Qing Zhou, Erik Olson, Show-Ling Shyng. Biochemistry & Molecular Biology, OHSU, Portland, OR, USA. The b-cell ATP-sensitive potassium (KATP) channel regulates insulin secretion by coupling glucose metabolism to membrane excitability. Mutations in the constituent protein subunits Kir6.2 and sulfonylurea receptor 1 (SUR1) that prevent channels from trafficking to the cell surface are frequent causes of congenital hyperinsulinism. We recently reported that carbamazepine, an anticonvulsant, corrects the trafficking defects caused by mutations in the N-terminal transmembrane domain of SUR1. In addition, carbamazepine inhibits the function of rescued channels that can be reversed by subsequent drug removal. Here, we investigated the mechanism underlying carbamazepine's effects on KATP channel trafficking and gating by partial proteolysis and electrophysiology, respectively. We show that carbamazepine inhibits channel activity by specifically abolishing channel response to the physiological stimulator MgADP. Our partial proteolysis results show that carbamazepine interacts with the channel complex and protects the N-terminus of Kir6.2 against trypsin digestion. Further, results show that deletion of Kir6.2 N-terminal 30 amino acids severely compromised carbamazepine mediated rescue of the SUR1 trafficking mutant, F27S. Our findings suggest a structural model for carbamazepine mediated rescue of SUR1-TMD0 trafficking mutants and inhibition of KATP channels. The conductance of potassium channels can be regulated by C-type inactivation, which consists in the time-dependent closing of their selectivity filter following activation. Crystallization of the KcsA channel from S. lividans under conditions of low potassium concentration revealed conformational changes of the selectivity filter preventing the permeation of both K and Na ions. This structure was associated with the C-type inactivated state of K channels. Under similar low potassium crystallization conditions, MthK from M. thermoautotrophicum, another model potassium channel, remains in its canonical conductive state. Functional studies nevertheless show that MthK undergo C-type inactivation like KcsA. In KcsA, the transition to the inactivated state is favored by a glutamate in the vicinity of the selectivity filter (Glu71). Mutation of this residue to alanine decreases inactivation drastically. Our electrophysiology and molecular simulation data show that, in MthK, a mutation of a valine at the same position to a glutamate (V55E) accelerates inactivation and results in a conformation of the selectivity filter similar to the inactivated state of KcsA. These results support the idea that potassium channels can potentially adopt two different inactivated states. We further investigate changes in ion binding affinity in MthK and KcsA channel mutants to understand the underlying difference in inactivation behavior using molecular dynamic simulations, free energy calculations and electrophysiological measurements.
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Structural Modeling of KCa3.1 Channel Interaction with Small Molecules Vladimir Yarov-Yarovoy, Heike Wulff. University of California Davis, Davis, CA, USA. The intermediate-conductance KCa3.1 channel and the related smallconductance KCa2 channels constitute potential pharmacological targets for immunosuppression, fibroproliferative disorders, hypertension and various neurological diseases. However, there currently is no available crystal structure or molecular model of these medically relevant targets that could be used for structure-assisted drug design. We used the Kv1.2-Kv2.1 channel structure (pdb id: 2R9R) as a template to generate a homology model of the KCa3.1 channel transmembrane region with the Rosetta modeling method. Docking of small molecules that are known to block KCa3.1 channel currents using Rosetta Dock generated structural channel -drug complexes that can be validated using experimental approaches. The lowest energy confirmation of the KCa3.1 channel complex with TRAM-34 identified T250 and V275 as interaction sites, two residues which had been previously demonstrated to completely abolish triarylmethane sensitivity when mutated to the corresponding residues in KCa2.3 channel. The model further correctly identified the interaction of the benzothiazinone-type KCa3.1 channel blocker NS6180 with T250 and V275 in KCa3.1 channel and modeled binding of the negative KCa2 channel gating modulator NS8593 to a KCa3.1-T250S-V275A mutant channel, which is blocked more potently by NS8593 than the WT-KCa2.3 channel. For the dihydropyridine nifedipine, which blocks KCa3.1 channels with low micromolar activity, the Rosetta model suggested a receptor site located between the pore lining S5 and S6 segment in agreement with available experimental data showing that nifedipine does not interact with T250 in the selectivity filter. The Rosetta KCa2/3 channel models can be used to understand the molecular mechanism of action of KCa channel blockers and gating modulators and assist with drug design efforts. Supported by RO1 GM076063 (to H.W.) and UC Davis startup (to V.Y-Y.). -activated K þ channel KCa3.1 (also known as KCNN4, IK1 or the Gárdos channel) plays an important role in the activation of T-and B-cells, mast cells, macrophages and microglia by regulating membrane potential, cellular volume and calcium signaling. KCa3.1 is further involved in the proliferation of dedifferentiated vascular smooth muscle cells and fibroblast and endothelium-derived hyperpolarization (EDH) responses in the vascular endothelium. Accordingly, KCa3.1 inhibitors are therapeutically interesting as immunosuppressants and for the treatment of a wide range of fibroproliferative disorder, while KCa3.1 activators constitute a potential new class of endothelial function preserving antihypertensives. Here, we report the development of QPatch assays for both KCa3.1 inhibitors and activators. During assay optimization, the Ca 2þ sensitivity of KCa3.1 was studied using varying intracellular Ca 2þ concentrations. A free Ca 2þ concentration of 1 mM was chosen to optimally test inhibitors.
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